Consensus on barriers and strategies for optimal clinical practice use of GLP-1 RAs in patients with type 2 diabetes and high cardiovascular risk or established cardiovascular disease.
Consensus on barriers and strategies for optimal clinical practice use of GLP-1 RAs in patients with type 2 diabetes and high cardiovascular risk or established cardiovascular disease.